Pregabalin Capsule 50 mg

Adult dose

This medication is administered orally in two divided doses throughout the day, regardless of meals. 1. Neuropathic Pain - Peripheral neuropathic pain: starting dose is 150 mg once daily; after 3 to 7 days, can be increased to 300 mg once daily, and if needed, can be further increased to a maximum of 600 mg once daily at intervals of 7 days. - Central neuropathic pain: starting dose is 150 mg once daily; after 1 week, it can be increased to 300 mg once daily.

Child dose

There is insufficient safety and efficacy data available for children under 12 years and adolescents aged 12-17, hence administration is not recommended.

This medication may increase the risk of suicidal ideation or behavior; therefore, patients should immediately inform their healthcare provider of any changes in mood or behavior during treatment. Patients with hypersensitivity to this drug or a genetic problem of lactose intolerance should not take it. Diabetic patients should be cautious as weight gain may necessitate adjustments in blood sugar control medications. If symptoms of angioedema occur, the medication should be discontinued immediately, and consultation with a healthcare provider is necessary. Elderly patients should be cautious due to the higher risk of falls from dizziness or drowsiness. Temporary visual blurring or changes in vision may occur; if symptoms are severe, discontinuation of the medication should be considered. Abrupt discontinuation of this medication can lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety; therefore, it should be tapered off gradually under the guidance of a healthcare provider. Patients with a history of drug abuse may be at a higher risk of misuse of this medication and should use it cautiously. Patients with impaired renal function may require dosage adjustments. Patients with heart disease should be cautious as this medication may worsen symptoms of heart failure during administration. When used in conjunction with other medications that have central nervous system depressant effects, the risk of drowsiness or respiratory depression may increase. During early pregnancy, there is a risk of birth defects; thus, women who are pregnant or planning to become pregnant must consult with a healthcare provider. This medication may pass into breast milk, so it is recommended to discontinue breastfeeding or the medication while nursing. Patients should avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness has resolved after taking this medication. In cases of overdose, symptoms such as altered consciousness, drowsiness, and confusion may occur, and immediate emergency treatment is necessary. Keep out of reach of children and ensure it is not transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, cold sweat, symptoms resembling anaphylaxis, angioedema, difficulty breathing, respiratory depression, pulmonary edema, loss of consciousness, vision abnormalities, visual field loss, jaundice, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), severe allergic reactions, serious neurological symptoms (loss of consciousness, mental disorders, paralysis, seizures), congestive heart failure, decreased urination, renal failure, urinary retention, nephropathy

Mild side effects

• Dizziness
• drowsiness
• confusion
• derealization
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to keep the storage temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with purple upper part and white lower part containing white powder.

Package unit

30 capsules/bottle